Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416272 · ClinicalTrials.gov registry record · NA
Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01416272 is a NA study that was terminated before completion, run by Bausch & Lomb Incorporated. The registered enrollment target is 12 participants.
The verdict
NCT01416272, a NA study, was terminated before completion, sponsored by Bausch & Lomb Incorporated.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.
Interventions
- DEVICE KeraSoft IC Soft Contact Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416272
The ClinicalTrials.gov registry entry for NCT01416272 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KeraSoft IC Soft Contact Lenses is the first listed.
NCT01416272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416272 about?
NCT01416272 is a clinical study titled "Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses". The objective of this twelve month dispensing study is to evaluate the clinical performance, particularly comfort and vision, of KeraSoft IC Soft Contact Lenses.
What is the current status of trial NCT01416272?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2011-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01416272?
The interventions under investigation include: KeraSoft IC Soft Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT01416272?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.